Low levels of human HIP14 are sufficient to rescue neuropathological, behavioural, and enzymatic defects due to loss of murine HIP14 in Hip14-/- mice

by Young F.B., Franciosi S., Spreeuw A., Deng Y., Sanders S., Tam N.C.M., Huang K., Singaraja R.R., Zhang W., Bissada N., Kay C., Hayden M.R.
Published 2018

Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease

by Garcia-Miralles, M, Hong, X, Tan, L.J, Caron, N.S, Huang, Y, To, X.V, Lin, R.Y, Franciosi, S, Papapetropoulos, S, Hayardeny, L, Hayden, M.R, Chuang, K.-H, Pouladi, M.A
Published 2020

Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice

by Wong B.K.Y., Ehrnhoefer D.E., Graham R.K., Martin D.D.O., Ladha S., Uribe V., Stanek L.M., Franciosi S., Qiu X., Deng Y., Kovalik V., Zhang W., Pouladi M.A., Shihabuddin L.S., Hayden M.R.
Published 2016

Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease

by Southwell A.L., Franciosi S., Villanueva E.B., Xie Y., Winter L.A., Veeraraghavan J., Jonason A., Felczak B., Zhang W., Kovalik V., Waltl S., Hall G., Pouladi M.A., Smith E.S., Bowers W.J., Zauderer M., Hayden M.R.
Published 2016